Pharming Group N.V.
PHAR • NASDAQ
Pharming Group N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Fabrice Chouraqui, with a market cap of $1.1B.
CEOFabrice Chouraqui
Next Earnings
Upcoming earnings announcement for Pharming Group N.V.
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (1:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.02
Revenue Estimate
$86.2M
Earnings History
Past 12 earnings reports for Pharming Group N.V.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | $0.07Est: $0.07 | 0.0% | $106.5MEst: $95.7M | +11.2% | — |
| Nov 6, 2025 | Q3 2025 | $0.10Est: $0.02 | +400.0% | $97.3MEst: $84.8M | +14.8% | — |
| Jul 31, 2025 | Q2 2025 | $0.06Est: -$0.05 | +220.0% | $93.2MEst: $75.3M | +23.8% | — |
| May 8, 2025 | Q1 2025 | -$0.22Est: -$0.03 | -633.3% | $79.1MEst: $58.9M | +34.3% | — |
| Mar 13, 2025 | Q4 2024 | $0.05Est: $0.01 | +400.0% | $92.7MEst: $76.7M | +20.9% | — |
| Oct 24, 2024 | Q3 2024 | -$0.02Est: $0.01 | -300.0% | $74.8MEst: $76.9M | -2.7% | — |
| Aug 1, 2024 | Q2 2024 | -$0.02 | — | $74.1M | — | — |
| May 8, 2024 | Q1 2024 | -$0.19 | — | $55.6M | — | — |
| Mar 14, 2024 | Q4 2023 | -$0.04 | — | $81.2M | — | — |
| Oct 26, 2023 | Q3 2023 | $0.05 | — | $66.7M | — | — |
| Aug 3, 2023 | Q2 2023 | $0.00 | — | $54.9M | — | — |
| May 11, 2023 | Q1 2023 | -$0.02 | — | $42.5M | — | — |